Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated
Pediatric Endocrinology

Resistance to thyrotropin-releasing hormone syndrome: A Patient Guide

At a Glance

TRH resistance syndrome can cause central hypothyroidism with low thyroid hormone even when a newborn TSH screen looks normal. Doctors should check adrenal function first, then use levothyroxine and monitor Free T4, growth, and energy rather than TSH.

Resistance to thyrotropin-releasing hormone (TRH) syndrome is an exceptionally rare genetic condition that disrupts the vital communication between the brain and the thyroid gland. In a healthy body, the brain releases TRH to tell the pituitary gland to produce thyroid-stimulating hormone (TSH), which in turn tells the thyroid gland to produce its own hormones. For a child with TRH resistance, the thyroid gland is structurally capable of working, but the pituitary gland’s receptors are essentially “deaf” to the brain’s signals [1][2]. Because the pituitary cannot receive the instructions to start, the body ends up with low levels of thyroid hormone, a state known as central hypothyroidism [3].

One of the most challenging aspects of this diagnosis is that it is often invisible to standard medical screening. Many newborn screening programs only measure TSH levels, looking for the high TSH levels that signal a problem with the thyroid gland itself. Because a child with TRH resistance has a pituitary gland that produces TSH at “normal” but inappropriately low levels, they can pass a TSH-only screen even while their actual thyroid hormone levels are low [4][5]. Screening programs vary by state and country, so it is helpful to ask your local program how they screen. This pattern makes it essential for doctors to look beyond TSH and specifically measure Free T4, the main circulating hormone that powers the body’s growth and development [1].

Because the pituitary gland is the master controller for multiple systems, doctors must evaluate other pituitary functions before beginning treatment. It is a critical medical rule that the hypothalamic-pituitary-adrenal axis—which controls the “stress hormone” cortisol—must be assessed before starting any thyroid medication [6][7]. If a child is low on cortisol, starting thyroid hormone first can speed up the body’s metabolism and trigger a life-threatening adrenal crisis [8]. Ensuring that the body can safely handle the thyroid hormone is the first priority.

Once safety is established, the standard treatment involves a daily, long-term dose of levothyroxine to replace the hormone the body isn’t making. Unlike more common primary thyroid issues, your child’s progress cannot be tracked by watching their TSH levels, as that signaling system remains permanently impaired [1]. Instead, success is measured by carefully monitoring Free T4 levels and tracking your child’s growth and energy [4]. With early, consistent medication and expert monitoring, prompt treatment supports healthy growth and neurodevelopment.

Important: Never start, stop, or change the dose of levothyroxine or any other prescribed hormone without explicit instructions from your treating endocrinologist.

Common questions in this guide

What is resistance to thyrotropin-releasing hormone syndrome?
It is a rare genetic condition in which the pituitary gland does not respond normally to the brain’s TRH signal. As a result, the body may have too little thyroid hormone, causing central hypothyroidism even though the thyroid gland itself may be structurally able to work.
Can standard newborn screening miss TRH resistance syndrome?
Yes. A screen that checks only TSH may look normal because the pituitary can produce a TSH level that is normal but too low for the child’s low thyroid hormone level. Testing Free T4 can help detect this form of central hypothyroidism, and screening methods differ by location.
Why is adrenal testing needed before starting levothyroxine?
The adrenal glands make cortisol, which helps the body respond to stress. If cortisol is low, starting thyroid hormone first can raise the body’s demands and trigger a life-threatening adrenal crisis, so clinicians check adrenal function before treatment.
How is TRH resistance syndrome treated?
Once treatment is considered safe, clinicians usually prescribe a daily, long-term dose of levothyroxine to replace the thyroid hormone the body lacks. The treating endocrinologist should choose and adjust the dose based on follow-up testing and the child’s growth and well-being.
How do doctors monitor levothyroxine when TSH cannot be trusted?
TSH is not a reliable dose marker because the pituitary’s response to TRH remains impaired. Doctors instead follow Free T4 levels and assess growth, energy, and development to judge whether treatment is working.

Get notified when new evidence is published on Resistance to thyrotropin-releasing hormone syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Central Hypothyroidism Due to a TRHR Mutation Causing Impaired Ligand Affinity and Transactivation of Gq.

    García M, González de Buitrago J, Jiménez-Rosés M, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(7)):2433-2442 doi:10.1210/jc.2016-3977.

    PMID: 28419241
  2. 2

    Recent advances in research on isolated congenital central hypothyroidism.

    Tajima T, Nakamura A, Oguma M, Yamazaki M

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2019; (28(3)):69-79 doi:10.1297/cpe.28.69.

    PMID: 31384098
  3. 3

    A Novel Thyrotropin-Releasing Hormone Receptor Missense Mutation (P81R) in Central Congenital Hypothyroidism.

    Koulouri O, Nicholas AK, Schoenmakers E, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(3)):847-51 doi:10.1210/jc.2015-3916.

    PMID: 26735259
  4. 4

    Low free thyroxine and normal thyroid-stimulating hormone in infants and children: possible causes and diagnostic work-up.

    Lauffer P, van Trotsenburg ASP, Zwaveling-Soonawala N

    European journal of pediatrics 2021; (180(7)):2333-2338 doi:10.1007/s00431-021-03976-6.

    PMID: 33585976
  5. 5

    Congenital isolated central hypothyroidism: Novel mutations and their functional implications.

    Boelen A, van Trotsenburg ASP, Fliers E

    Handbook of clinical neurology 2021; (180()):161-169 doi:10.1016/B978-0-12-820107-7.00010-0.

    PMID: 34225927
  6. 6

    2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism.

    Persani L, Brabant G, Dattani M, et al.

    European thyroid journal 2018; (7(5)):225-237 doi:10.1159/000491388.

    PMID: 30374425
  7. 7

    Subclinical hypothyroidism or central hypothyroidism-The danger of thyroid function misinterpretation.

    Anyiam O, Cheung B, Al-Sabbagh S

    Clinical case reports 2018; (6(10)):1953-1957 doi:10.1002/ccr3.1694.

    PMID: 30349705
  8. 8

    Refractory Pericardial Effusion Secondary to Central Hypothyroidism due to Empty Sella Syndrome: A Rare Case Report.

    Mandal B, Subedi P, Yadav BK, et al.

    Clinical case reports 2026; (14(10)):e73399 doi:10.1002/ccr3.73399.

    PMID: 42840647

This page is for informational purposes only and does not constitute medical advice. Your child’s endocrinologist should interpret test results and direct treatment; never start, stop, or change levothyroxine or other hormone treatment without explicit instructions.